Waris Waris

NPI: 1891807822
Total Payments
$11,096
2024 Payments
$1,733
Companies
45
Transactions
671
Medicare Patients
2,114
Medicare Billing
$329,671

Payment Breakdown by Category

Food & Beverage$10,270 (92.6%)
Education$826.11 (7.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,270 649 92.6%
Education $826.11 22 7.4%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $2,084 133 $0 (2024)
E.R. Squibb & Sons, L.L.C. $1,746 129 $0 (2024)
PFIZER INC. $953.88 62 $0 (2024)
Merck Sharp & Dohme LLC $802.75 53 $0 (2023)
Celgene Corporation $550.70 34 $0 (2024)
Incyte Corporation $544.55 23 $0 (2024)
Astellas Pharma US Inc $532.65 15 $0 (2024)
Amgen Inc. $472.80 21 $0 (2023)
Daiichi Sankyo Inc. $423.42 31 $0 (2024)
Eisai Inc. $420.96 21 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,733 92 E.R. Squibb & Sons, L.L.C. ($282.99)
2023 $1,476 87 Novartis Pharmaceuticals Corporation ($245.75)
2022 $1,908 113 Novartis Pharmaceuticals Corporation ($430.88)
2021 $920.43 61 Novartis Pharmaceuticals Corporation ($260.46)
2020 $467.00 30 E.R. Squibb & Sons, L.L.C. ($90.58)
2019 $1,690 106 E.R. Squibb & Sons, L.L.C. ($357.57)
2018 $1,424 92 Novartis Pharmaceuticals Corporation ($298.43)
2017 $1,478 90 Novartis Pharmaceuticals Corporation ($348.91)

All Payment Transactions

671 individual payment records from CMS Open Payments — Page 1 of 27

Date Company Product Nature Form Amount Type
12/23/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $27.08 General
Category: Hematology
12/17/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $13.74 General
Category: Oncology
12/16/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $17.77 General
Category: ONCOLOGY
12/11/2024 Astellas Pharma US Inc Vyloy (Drug) Food and Beverage In-kind items and services $24.24 General
Category: Oncology
12/11/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $15.50 General
Category: Oncology
12/10/2024 Astellas Pharma US Inc Education In-kind items and services $96.00 General
12/05/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $17.17 General
Category: Oncology
12/04/2024 ABBVIE INC. EPKINLY (Drug), IMBRUVICA Food and Beverage In-kind items and services $22.25 General
Category: ONCOLOGY
11/21/2024 PFIZER INC. IBRANCE (Drug), TUKYSA Food and Beverage In-kind items and services $14.88 General
Category: ONCOLOGY
11/19/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $18.29 General
Category: Oncology
11/19/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.64 General
Category: Cardiovascular
11/14/2024 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Food and Beverage In-kind items and services $27.71 General
Category: HEMATOLOGY/ONCOLOGY
11/13/2024 Novocure Inc. Optune Lua (NovoTTF-200T) (Device) Food and Beverage Cash or cash equivalent $17.89 General
Category: Oncology
11/12/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $13.63 General
Category: Hematology
11/07/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $19.66 General
Category: Oncology
11/06/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $14.72 General
Category: ONCOLOGY
11/06/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $2.41 General
Category: ONCOLOGY
10/17/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $14.58 General
Category: Oncology
10/14/2024 Astellas Pharma US Inc Education In-kind items and services $96.00 General
10/14/2024 GlaxoSmithKline, LLC. ZEJULA (Drug) Food and Beverage In-kind items and services $14.51 General
Category: ONCOLOGY
10/10/2024 ABBVIE INC. IMBRUVICA (Drug) Food and Beverage In-kind items and services $22.09 General
Category: ONCOLOGY
10/10/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $20.78 General
Category: Oncology
10/07/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $16.58 General
Category: ONCOLOGY
10/01/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $9.16 General
Category: Cardiovascular
09/26/2024 Incyte Corporation MONJUVI (Drug), PEMAZYRE Food and Beverage Cash or cash equivalent $9.47 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 469 1,003 $180,340 $71,213
2022 6 510 1,276 $215,222 $83,695
2021 8 555 1,401 $234,967 $92,522
2020 8 580 1,318 $220,362 $82,240
Total Patients
2,114
Total Services
4,998
Medicare Billing
$329,671
Procedure Codes
27

All Medicare Procedures & Services

27 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 106 403 $58,080 $24,268 41.8%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 119 146 $39,709 $14,401 36.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 129 258 $36,461 $14,377 39.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 66 147 $30,523 $12,841 42.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 49 49 $15,567 $5,324 34.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 186 527 $74,476 $30,643 41.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 105 464 $66,872 $25,281 37.8%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 107 127 $34,541 $12,848 37.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 61 107 $22,217 $8,963 40.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 40 40 $12,708 $4,283 33.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 11 11 $4,408 $1,677 38.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 183 545 $77,019 $31,487 40.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 125 533 $76,816 $29,633 38.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 115 139 $37,805 $14,619 38.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 48 48 $15,250 $5,804 38.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 35 45 $9,344 $3,912 41.9%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 24 25 $10,019 $3,810 38.0%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 14 55 $4,307 $1,641 38.1%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 11 11 $4,408 $1,617 36.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 204 583 $82,390 $29,279 35.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 112 398 $57,360 $22,600 39.4%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 110 128 $34,813 $13,623 39.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 34 37 $14,827 $5,794 39.1%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 45 45 $14,297 $4,568 32.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 34 36 $7,475 $2,738 36.6%

About Waris Waris

Waris Waris is a Internal Medicine healthcare provider based in Logan, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891807822.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Waris Waris has received a total of $11,096 in payments from pharmaceutical and medical device companies, with $1,733 received in 2024. These payments were reported across 671 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($10,270).

As a Medicare-enrolled provider, Waris has provided services to 2,114 Medicare beneficiaries, totaling 4,998 services with total Medicare billing of $329,671. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Medical Oncology
  • Location Logan, WV
  • Active Since 08/31/2006
  • Last Updated 01/07/2010
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1891807822

Products in Payments

  • OPDIVO (Biological) $1,387
  • KEYTRUDA (Biological) $738.47
  • KISQALI (Drug) $538.12
  • TASIGNA (Drug) $359.96
  • ELIQUIS (Drug) $336.78
  • Lenvima (Drug) $329.56
  • Enhertu (Drug) $285.20
  • JAKAFI (Drug) $266.14
  • AFINITOR (Drug) $254.95
  • MEKINIST (Drug) $236.29
  • LUMAKRAS (Drug) $230.33
  • XTANDI (Drug) $229.92
  • RYDAPT (Drug) $189.20
  • CHANTIX (Drug) $187.64
  • LIBTAYO (Biological) $177.77
  • REBLOZYL (Biological) $172.09
  • Xtandi (Drug) $159.77
  • Pomalyst (Drug) $153.28
  • IMBRUVICA (Drug) $146.00
  • LYNPARZA (Drug) $142.94

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Logan